A batch-specific Certificate of Analysis (COA) is available identifying lot number, purity percentage, testing methodology, and third-party laboratory credentials
Adults with type 1 diabetes who used a GLP-1 receptor agonist or other incretin-based drug had lower risk for all-cause mortality, hospitalization and other clinical health outcomes than those not using a GLP-1, according to study data
The lawsuits claim plaintiffs who used the drugs suffered severe side effects such as stomach paralysis, bowel obstructions, and vision loss, along with failure-to-warn and misleading marketing
Patients will need a new prescription at the appropriate dose
That is your job, managed through deliberate protein intake and resistance training even when hunger is essentially absent